News

NeoPharm has enrolled its first patients in its multi-center open-label trial of LEP-ETU for efficacy and safety in patients with metastatic breast cancer.

Company’s lead product AMR-001 is an autologous stem cell product for the treatment of damaged heart muscle following AMI.

BGI and PentaBase plan to co-develop Real-Time PCR kits for the detection of important clinical biomarkers.

Company reports promising preclinical in vitro data in support of the company’s P.L.E.A.S.E.® intraepidermal drug delivery platform.

deCODE report in the journal Nature how a single variant in the sequence of the genome confers nicotine dependence and risk of lung cancer and other disease.

NIH has launched an online resource to enable scientists to access a wealth of information about proteins and to speed discovery about these molecules.

Features content covering topics from pipette calibration to performance verification of automated liquid handlers and proper pipetting technique.

Both companies sign a letter of intent to add genetic testing to expand both companies' personalized medicine services in the U.S. and internationally.

The new features incorporated into Version 8.0 were determined in consultation with the Simcyp Consortium, which currently includes nine out of the top ten pharmaceutical companies worldwide.

Inherited variations in the amount of an innate anxiety-reducing molecule help explain why some people can withstand stress better than others, according to study.